| Jan'20 | Jan'19 | Jul'17 | Jul'16 | Jul'15 | Jul'14 | Jul'13 | Jul'12 | Jul'11 | Jul'10 |
|---|---|---|---|---|---|---|---|---|---|
Interest Paid, Excluding Capitalized Interest, Operating Activities | |||||||||
26,655 | 22,312 | 16,505 | 15,917 | 25,369 | 25,291 | 21,414 | 15,443 | 17,296 | 13,131 |
Gain (Loss) on Extinguishment of Debt | |||||||||
-76 | 0 | 0 | -16,260 | - | - | - | - | - | - |
Payment for Debt Extinguishment or Debt Prepayment Cost | |||||||||
- | - | - | 14,243 | - | - | - | - | - | - |
Purchase of 8.125% senior subordinated notes due 2015 | |||||||||
- | - | - | - | - | - | - | - | 135,350 | - |
Debt financing costs | |||||||||
0 | 7,275 | 70 | 16,376 | 3,854 | 0 | 6,739 | 0 | 5,177 | 3,233 |
Payments for Repurchase of Common Stock | |||||||||
0 | 0 | 62,909 | 169,997 | 87,146 | 9,999 | 15,203 | 12,960 | 64,548 | 4,489 |
Proceeds from issuance of 0.75% convertible senior notes due 2021 | |||||||||
- | - | - | 485,000 | 0 | 0 | 93,825 | 0 | 187,500 | - |
Proceeds from sale of warrants | |||||||||
- | - | - | 74,690 | 0 | 0 | - | - | - | - |
Payments for Hedge, Financing Activities | |||||||||
- | - | - | 115,818 | 0 | 0 | - | - | - | - |
Extinguishment of 0.75% senior notes | |||||||||
25,000 | 0 | 0 | 277,500 | 0 | 0 | - | - | - | 0 |
Redemption discount on convertible debt, net of costs | |||||||||
675 | 0 | 0 | - | - | - | - | - | - | - |
Proceeds from Derivative Instrument, Financing Activities | |||||||||
388 | 0 | 0 | - | - | - | - | - | - | - |
Purchase of warrants | |||||||||
301 | 0 | 0 | - | - | - | - | - | - | - |
Cash flows from operating activities: | |||||||||
Net (loss) income | |||||||||
57,215 | 62,907 | 157,217 | 128,740 | 84,324 | 39,978 | 35,188 | 39,378 | 16,107 | 5,849 |
Adjustments to reconcile net (loss) income to net cash used in operating activities: | |||||||||
Depreciation and amortization | |||||||||
187,556 | 179,603 | 147,906 | 124,940 | 96,044 | 92,772 | 85,481 | 62,693 | 62,533 | 63,607 |
Non-cash lease expense | |||||||||
30,043 | 0 | 0 | - | - | - | - | - | - | - |
Deferred income tax (benefit) provision | |||||||||
9,261 | 8,523 | 18,233 | 26,782 | 1,244 | -6,323 | -2,270 | 9,874 | 14,728 | 1,921 |
Stock-based compensation | |||||||||
10,034 | 20,187 | 20,805 | 16,850 | 13,923 | 12,596 | 9,902 | 6,782 | 4,409 | 3,351 |
Provision for bad debt (recovery), net | |||||||||
-6,540 | 17,071 | 199 | 1,252 | 465 | 615 | 139 | 186 | -23 | 198 |
Gain on sale of fixed assets | |||||||||
14,879 | 19,390 | 14,866 | 9,806 | 7,110 | 10,706 | 4,683 | 15,430 | 10,216 | 7,677 |
Write-off of deferred financing fees and premium on long-term debt | |||||||||
- | - | - | - | 0 | 0 | 321 | 0 | 2,337 | 0 |
Amortization of debt discount | |||||||||
20,112 | 19,103 | 17,610 | 14,709 | 0 | 0 | -218 | 0 | 0 | - |
Amortization of premium on long-term debt | |||||||||
- | - | - | 94 | 397 | - | - | - | - | - |
Amortization of debt issuance costs and other | |||||||||
4,023 | 3,686 | 3,323 | 2,875 | 2,040 | 1,916 | 1,652 | 1,297 | 1,295 | 1,114 |
Excess tax benefit from share-based awards | |||||||||
0 | 0 | 8,385 | 13,003 | 8,371 | 3,025 | 1,283 | 1,625 | 0 | 69 |
Other | |||||||||
- | - | - | - | - | - | 57 | -105 | 87 | 52 |
Change in operating assets and liabilities, net of acquisitions: | |||||||||
Accounts receivable, net | |||||||||
195,796 | 30,750 | 33,068 | -2,729 | 40,444 | 16,949 | -3,625 | 3,421 | 21,665 | -4,617 |
Contract assets, net | |||||||||
35,888 | 149,828 | 27,773 | 70,957 | 41,021 | 25,356 | 12,338 | 35,693 | 23,157 | -776 |
Other current assets and inventories | |||||||||
6,960 | 15,842 | 13,232 | 13,800 | 1,138 | 12,843 | 1,083 | 6,403 | 5,014 | 6,348 |
Other assets | |||||||||
-41,068 | 25,110 | -2,064 | 2,936 | 6,875 | 555 | 31 | -62 | -617 | 1,004 |
Income taxes receivable/payable | |||||||||
84 | -10,357 | 13,189 | -20,148 | -11,758 | -6,685 | -5,994 | -5,747 | 5,025 | -3,294 |
Accounts payable | |||||||||
-2,141 | 20,064 | 977 | 15,132 | 7,114 | -4,244 | -11,163 | 2,978 | 2,580 | -1,557 |
Accrued liabilities, insurance claims, operating lease liabilities, and other liabilities | |||||||||
-39,101 | 23,866 | -1,378 | 15,910 | 30,344 | 9,993 | -2,546 | -1,195 | 4,264 | -13,986 |
Net cash provided by (used in) operating activities | |||||||||
57,999 | 124,447 | 256,443 | 275,731 | 141,900 | 84,185 | 106,744 | 65,125 | 43,857 | 54,138 |
Cash flows from investing activities: | |||||||||
Capital expenditures | |||||||||
120,574 | 164,963 | 201,197 | 186,011 | 102,997 | 89,136 | 64,650 | 77,612 | 61,457 | 55,376 |
Proceeds from sale of assets | |||||||||
19,045 | 22,949 | 16,029 | 10,540 | 9,392 | 15,407 | 5,827 | 24,783 | 12,305 | 8,768 |
Cash paid for acquisitions, net of cash acquired | |||||||||
0 | 20,917 | 26,070 | 157,183 | 31,909 | 17,088 | 330,291 | 0 | 36,451 | 0 |
Changes in restricted cash and other | |||||||||
- | - | - | - | 538 | 303 | -60 | -926 | -225 | 0 |
Proceeds from acquisition working capital adjustment | |||||||||
0 | 0 | 1,825 | 0 | 0 | - | - | - | - | - |
Other investing activities | |||||||||
-306 | -1,576 | -666 | 0 | 4,000 | 0 | 0 | - | - | - |
Net cash used in investing activities | |||||||||
-101,223 | -161,355 | -208,747 | -332,654 | -130,052 | -91,120 | -389,054 | -51,903 | -85,378 | -46,608 |
Proceeds from Term Loan on Senior Credit Agreement | |||||||||
- | - | - | - | - | - | - | 0 | 0 | - |
Proceeds from issuance of 7.125% senior subordinated notes due 2021 (including $3.8 million premium on fiscal 2013 issuance) | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Proceeds from Long-term Lines of Credit | |||||||||
475,000 | 423,188 | 707,000 | 1,310,000 | 535,750 | 502,000 | 529,500 | 0 | 0 | - |
Cash flows from financing activities: | |||||||||
Principal payments on senior credit agreement, including term loans | |||||||||
480,625 | 331,250 | 685,563 | 1,209,000 | 467,563 | 495,813 | 358,625 | 0 | 0 | - |
Exercise of stock options | |||||||||
503 | 871 | 1,449 | 2,745 | 8,922 | 14,568 | 5,253 | 6,490 | 1,321 | 33 |
Restricted stock tax withholdings | |||||||||
1,698 | 4,657 | 10,767 | 12,604 | 4,711 | 3,781 | 884 | -329 | -197 | 274 |
Excess tax benefit from share-based awards | |||||||||
0 | 0 | 8,385 | 13,003 | 8,371 | 3,025 | 1,283 | 1,625 | 0 | 69 |
Principal payments on other financing activities | |||||||||
- | - | - | - | 1,000 | 1,000 | 74 | 233 | 582 | 1,023 |
Net cash provided by (used in) financing activities | |||||||||
-31,058 | 80,877 | -42,475 | 69,900 | -11,231 | 9,000 | 248,336 | -5,407 | -17,033 | -8,917 |
Net increase in cash and equivalents and restricted cash | |||||||||
-74,282 | 43,969 | 5,221 | 12,977 | 617 | 2,065 | -33,974 | 7,815 | -58,554 | -1,387 |
SUPPLEMENTAL DISCLOSURE OF OTHER CASH FLOW ACTIVITIES AND NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||||||
Cash paid for taxes, net | |||||||||
12,017 | 6,396 | 88,060 | 31,159 | 39,057 | 26,738 | 19,128 | 10,722 | 3,481 | 6,208 |
Purchases of capital assets included in accounts payable or other accrued liabilities at period end | |||||||||
8,814 | 6,795 | 21,978 | 7,196 | 2,372 | 2,651 | 13,639 | 4,593 | 10,173 | 885 |